Early detection of cervical carcinoma: Cytology of HPV test?;Früherkennung des zervixkarzinoms: Zytologie oder HPV-test?

Gynakologe

Volumn 35, Issue 2, 2002, Pages 181-192

  Schneider, A ^a   Scheungraber, C ^a   Hoyer, H ^a   Durst M ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CYTODIAGNOSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; DISEASE COURSE; EARLY DIAGNOSIS; HUMAN; INTERMETHOD COMPARISON; REVIEW; UTERINE CERVIX CARCINOMA; VIRUS DIAGNOSIS; WART VIRUS;

EID: 0036934272     PISSN: 00175994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00129-001-1125-9     Document Type: Review

References (45)

1. ALTS Group (2000) Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: Baseline data from a randomized trial. J National Cancer Institute 92: 397-402
2. Bollen LJ, Tjong AHS, Van V et al.(1999) Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology. Gynecol Oncol 72: 199-201
3. Bosch FX, Rohan T, Schneider A et al. (2001) Papillomavirus Research: Updating results to the year 2000. Highlights of the HPV 2000 International Papillomavirus conference. J Clin Pathol 54: 0-13
4. Campion MJ, McCance DJ, Cuzick J, Singer A (1986) Progressive potential of mild cervical atypia: prospective cytological, colposcopic, and virological study. Lancet 2: 237-240
5. Chesebro M (1997) High-risk human papillomavirus testing of women with cytological lowgrade squamous intraepithelial lesions. J Lower Genital Tract Dis 1: 234-239
6. Cox JT (1996) Clinical role of HPV testing. Obstet Gynecol Clin North Am 23: 811-851
7. Cox JT (1999) Evaluating the role of HPV testing for women with equivocal Papanicolaou test findings. JAMA 281: 1645-1647
8. Cox JT (1999) Management of cervical intraepithelial neoplasia. Lancet 353: 857-859
9. Cuzick J, Szarewski A, Terry G et al. (1995) Human papillomavirus testing in primary cervical screening. Lancet 345: 1533-1536
10. Dillner J (1998) Can cervical cancer screening programs be improved by incorporating screening for human papillomavirus infection? Cancer J 11: 272-276
11. Elfgren K, Bistoletti P, Dillner L, Walboomers JM, Meijer CJ, Dillner J (1996) Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens. Am J Obstet Gynecol 174: 937-942
12. Hayes VM, Hofstra RM, Buys CH, Hollema H, van der Zee AG 81998) Homozygous arginine-72 in wild type p53 and risk of cervical cancer. Lancet 352:1756
13. Hillemanns P (1999) Screening for cervical neoplasia by self-assessment for human papillomavirus DNA. Lancet 1999
14. Hording U, Junge J, Rygaard C, Lundvall F (1995) Management of low-grade CIN: follow-up or treatment? Eur J Obstet Gynecol Reprod Biol 62: 49-52
15. Jenkins D, Sherlaw-Johnson C, Gallivan S (1998) Assessing the role of HPV testing in cervical cancer screening. Papillomavirus Report 9: 89-101
16. Jenkins D, Sherlaw Johnson C, Gallivan S (1996) Can papilloma virus testing be used to improve cervical cancer screening? Int J Cancer 65: 768-773
17. Josefsson AM, Magnusson PK, Ylitalo N et al. (1998) p53 polymorphism and risk of cervical cancer. Nature 396: 531
18. Josefsson AM, Magnusson PK, Ylitalo N et al. (2000) Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 24: 2189-2193
19. Kinney WK, Manos MM, Hurley LB, Ransley JE (1998) Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses. Obstet Gynecol 91: 973-976
20. Klaes R, Woerner SM, Ridder R et al. (1999) Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res 59: 6132-6136
21. Koutsky LA, Holmes KK, Critchlow CW et al. (1992) A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 327:1272-1278
22. Kurman RJ, Henson DE, Herbst AL, Noller KL, Schiffman MH (1994) ft1 NCIW, Interim guidelines for the management of abnormal cervical cytology. J Am Med Assoc 271: 1866-1869
23. Lanham S, Campbell I, Watt P, Gornall R (1998) p53 polymorphism and risk of cervical cancer. Lancet 352: 1631
24. Manos MM, Kinney WK, Hurley LB et al. (1999) Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 281: 1605-1610
25. Mitchell H, Medley G (1990) Age and time trends in the prevalence of cervical intraepithelial neoplasia on Papanicolaou smear tests, 1970-1988. Med J Aust 152: 252-255
26. Nasiell K, Roger V, Nasiell M (1986) Behavior of mild cervical dysplasia during long-term followup. Obstet Gynecol 67: 665-669
27. Nindl I, Rindfleisch K, Lotz B, Schneider A, Durst M (1999) Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer. lnt J Cancer 82: 203-207
28. Nobbenhuis MAE, Walboomers JMM, Helmerhorst TJM et al. (1999) Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 354: 20-25
29. Peyton CL, Schiffman M, Lörincz AT et al. (1998) Comparison of PCR-and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J Clin Microbiol 36: 3248-3254
30. Qu WM, Jiang G, Cruz Y et al. (1997) PCR detection of human papillomavirus: Comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 35: 1304-1310
31. Ratnam S, Franco EL, Ferenczy A (2000) Human papillomavirus testing for primary screening of cervical cancer precursors. Cancer Epidemiol Biomarkers Prev 9: 945-951
32. Reid R, Greenberg MD, Loerincz A et al. (1991) Should cervical cytologic testing be augmented by cervicography or human papillomavirus deoxyribonucleic acid detection? Am J Obstet Gynecol 164: 1461-1469
33. Remmink AJ, Walboomers JM, Helmerhorst TJ et al. (1995) The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 61: 306-311
34. Ronnett BM, Manos MM, Ransley JE et al. (1999) Atypical glandular cells of undetermined significance (AGUS): cytopathologic features, histopathologic results, and human papillomavirus DNA detection. Hum Pathol 30: 816-825
35. Schneider A, Hoyer H, Lotz B et al. (2000) Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy. Int J Cancer 89: 529-534
36. Schneider A, Zahm DM, Kirchmayr R, Schneider V (1996) Screening for cervical intraepithelial neoplasia grade 2/3: validity of cytology study, cervicography and human papillomavirus detection. Am J Obstet Gynecol 174: 1534-1541
37. Sherman ME, Schiffman MH, Lorincz AT et al. (1997) Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing. Cancer; 81: 89-97
38. Solomon D, Schiffman M, Tarone R (2001) Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial. J Natl Cancer Inst 93: 293-299
39. Soutter WP, de Barros Lopes A, Fletcher A et al. (1997) Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia. Lancet 349: 978-980
40. Storey A, Thomas M, Kalita A et al. (1998) Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393: 229-234
41. Woodman CB, Collins S, Winter H et al. (2001) Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 357: 1831-1836
42. Wright TCJ, Denny L, Kuhn L, Pollack A, Lorincz A (2000) HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 283: 81-86
43. Wright TC, Lorincz A Jr, Ferris DG et al. (1998) Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears. Am J Obstet Gynecol 178: 962-966
44. Zehbe I, Tommasino M (1999) The biological significance of human papillomavirus type 16 variants for the development of cervical neoplasia. Papillomavirus Report 10: 105-116
45. Zehbe I, Voglino G, Wilander E, Genta F, Tommasino M (1999) Codon 72 polymorphism of p53 and its association with cervical cancer. Lancet 354: 218-219